Drug
Polaprezinc clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 1
- first study started
- 2015
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
3 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Jiangnan University (1) · Yonsei University (1) · University of Milan (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses polaprezinc is read from its arms, and is right about nine times in ten.
Testing it · 3
- Polaprezinc Treatment for Enzalutamide- or Abiraterone-resistant CRPCCompletedPhase 1/2Jiangnan UniversityNCT05549778Written as Polaprezinc group
- Efficacy of Zinc L-Carnosine Mouth RinseStatus unknownPhase 3University of MilanNCT04430998Written as Zinc L-Carnosine
- The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced UlcerCompletedNot applicableYonsei UniversityNCT02243618Written as Polaprezinc
Codes
What other systems call polaprezinc · ClinicalTrials.gg INT003469
- MeSH (NLM) C061957polaprezincConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0WA1B15A1ZPOLAPREZINCConfirmed FDA, NLM, Wikidata
- RxNorm 2179843One source FDA
- Wikidata Q22075875polaprezincConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C118371PolaprezincOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C061957 | polaprezinc | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0WA1B15A1Z | POLAPREZINC | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2179843 | — | One source FDA |
| Wikidata | Q22075875 | polaprezinc | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C118371 | Polaprezinc | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.